Intensity Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INTS and other ETFs, options, and stocks.About INTS
Intensity Therapeutics, Inc. is a clinical-stage biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine.
INTS Key Statistics
Stock Snapshot
As of today, Intensity Therapeutics(INTS) shares are valued at $3.20. The company's market cap stands at 10.45M, with a P/E ratio of -0.66.
Intensity Therapeutics(INTS) stock opened on 2026-10-27 at —. The price climbed to — and dipped to —.
The Intensity Therapeutics(INTS)'s current trading volume is 0, compared to an average daily volume of 23.34K.
During the past year, Intensity Therapeutics(INTS) stock moved between $3.00 at its lowest and $43.50 at its peak.
During the past year, Intensity Therapeutics(INTS) stock moved between $3.00 at its lowest and $43.50 at its peak.
INTS News
...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.